Drug Profile
Aciclovir controlled release - Avadel Pharmaceuticals
Alternative Names: Acyclovir controlled release (Micropump product) - Avadel Pharmaceuticals; Genvir; ViropumpLatest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator Flamel Technologies
- Class Antivirals; Eye disorder therapies; Hypoxanthines; Small molecules
- Mechanism of Action DNA-directed DNA polymerase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Herpes simplex virus infections
Most Recent Events
- 24 Jan 2017 Discontinued - Phase-III for Herpes simplex virus infections in Europe (PO) (Avadel Pharmaceuticals pipeline, January 2017)
- 24 Jan 2017 Discontinued - Preclinical for Herpes simplex virus infections in USA (PO) (Avadel Pharmaceuticals pipeline, January 2017)
- 26 Jan 2011 No development reported - Phase-III for Herpes simplex virus infections in Europe (PO)